The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene

Vascular Health and Risk Management

Volumn 4, Issue 5, 2008, Pages 1095-1102

  Zhang, Yong ^a   Ramos, Kenneth S ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Abdominal aortic aneurysm; Aorta; Benzo(a)pyrene; C57B 6J mice; Cigarette smoking

Indexed keywords

ANGIOTENSIN II; BENZO[A]PYRENE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA RUPTURE; AORTA WALL; ARTICLE; C57BL 6 MOUSE; CELL INFILTRATION; CIGARETTE SMOKING; CONTROLLED STUDY; HEMATOMA; HISTOPATHOLOGY; INCIDENCE; LAMELLAR BODY; MACROPHAGE; MALE; MOUSE; NONHUMAN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; BENZO(A)PYRENE; DISEASE MODELS, ANIMAL; ELASTIC TISSUE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; SMOKING;

EID: 56849087013     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alcorn HG, Wolfson Jr. SK, Sutton-Tyrrell K, et al. 1996. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 16:963-70.
2. [ATSDR] Agency for Toxic Substances and Disease Registry. 1995. Toxicological Profile For Polycyclic Aromatic Hydrocarbons. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry: 273.
3. Bengtsson H, Sonesson B, Bergqvist D. 1996. Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann N Y Acad Sci, 800:1-24.
4. Blanchard JF, Armenian HK, Friesen PP. 2000. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol, 151:575-83.
5. [CDCP] Centers for Disease Control and Prevention. 2002. National Hospital Discharge Survey: 2000 Annual Summary With Detailed Diagnosis and Procedure Data. Accessed on March 10, 2008. URL: http://www.cdc.gov/ nchs/data/series/sr_13/sr13_153.pdf.
6. Chang JB, Stein TA, Liu JP, et al. 1997. Risk factors associated with rapid growth of small abdominal aortic aneurysms. Surgery, 121:117-22.
7. Curfs DM, Lutgens E, Gijbels MJ, et al. 2004. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am J Pathol, 164:101-8.
8. Daugherty A, Cassis LA. 2002. Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep, 4:222-7.
9. Daugherty A, Manning MW, Cassis LA. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest, 105:1605-12.
10. Deng GG, Martin-McNulty B, Sukovich DA, et al. 2003. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res, 92:510-17.
11. Forester ND, Cruickshank SM, Scott DJ, et al. 2005. Functional characterization of T cells in abdominal aortic aneurysms. Immunology, 115:262-70.
12. Goodall S, Crowther M, Hemingway DM, et al. 2001. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation, 104:304-9.
13. Haque M, Francis J, Sehgal I. 2005. Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines. Cancer Lett, 225:159-66.
14. Holmes DR, Petrinec D, Wester W, et al. 1996. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res, 63:305-9.
15. Jamrozik K, Norman PE, Spencer CA, et al. 2000. Screening for abdominal aortic aneurysm: lessons from a population-based study. Med J Aust, 173:345-50.
16. Kochanek KD, Smith BL. 2004. Deaths: preliminary data for 2002. Natl Vital Stat Rep, 52:1-47.
17. Lecureur V, Ferrec EL, N'Diaye M, et al. 2005. ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett, 579:1904-10.
18. Longo GM, Buda SJ, Fiotta N, et al. 2005. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery, 137:457-62.
19. Longo GM, Xiong W, Greiner TC, et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest, 110:625-32.
20. Lopez-Candales A, Holmes DR, Liao S, et al. 1997. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol, 150:993-1007.
21. Martin-McNulty B, Tham DM, da Cunha V, et al. 2003. 17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 23:1627-32.
22. Nakashima H, Aoki M, Miyake T, et al. 2004. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors. Circulation, 109:132-8.
23. [NAS] National Academy of Sciences; Committee on Biologic Effects of Atmospheric Pollutants. 1972. Particulate Polycyclic Organic Matter. Washington, DC: National Academy of Sciences (National Research Council).
24. Parodi FE, Mao D, Ennis TL, et al. 2005. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB. J Vasc Surg, 41:479-89.
25. Patel MI, Hardman DT, Fisher CM, et al. 1995. Current views on the pathogenesis of abdominal aortic aneurysms. J Am Coll Surg, 181:371-92.
26. Pei XH, Nakanishi Y, Inoue H, et al. 2002. Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line. Cytokine, 19:236-41.
27. Pyo R, Lee JK, Shipley JM, et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest, 105:1641-9.
28. Raveendran M, Senthil D, Utama B, et al. 2004. Cigarette suppresses the expression of P4Halpha and vascular collagen production. Biochem Biophys Res Commun, 323:592-8.
29. Rodin MB, Daviglus ML, Wong GC, et al. 2003. Middle age cardiovascular risk factors and abdominal aortic aneurysm in older age. Hypertension, 42:61-8.
30. Rubini P, Bonati L, A. Parolari A, et al. 2001. [Inflammatory abdominal aortic aneurysms]. Minerva Chir, 56:287-98.
31. Schmeltz I, Hoffmann D, Wynder EL. 1974. Toxic and Tumorigenic Agents in Tobacco Smoke. Trace Substance Environment Health 8, Symposium.
32. Schmeltz I, Hoffmann D, Wynder EL. 1975. The influence of tobacco smoke on indoor atmospheres. Prev Med, 4:66-82.
33. Strachan DP. 1991. Predictors of death from aortic aneurysm among middle-aged men: the Whitehall study. Br J Surg, 78:401-4.
34. Thompson RW, Liao S, Curci JA. 1997. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis, 8:623-31.
35. Thompson RW, Parks WC. 1996. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci, 800:157-74.
36. Vardulaki KA, Walker NM, Day NE, et al. 2000. Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg, 87:195-200.
37. Wanhainen A, Bergqvist D, Boman K, et al. 2005. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg, 41:390-6.
38. Weng MW, Hsiao YM, Chen CJ, et al. 2004. Benzo[a]pyrene diol epoxide up-regulates COX-2 expression through NF-kappaB in rat astrocytes. Toxicol Lett, 151:345-55.
39. Wilmink TB, Quick CR, Day NE. 1999. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg, 30:1099-105.